NCT02402400

Sub Lingual Versus Traditional Oral Administration of Ticagrelor in Acute Coronary Syndrome/Non ST-elevation Myocardial Infarction - A Platelet Reactivity Study

Sub Lingual Versus Traditional Oral Administration of Ticagrelor in Acute Coronary Syndrome

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Sheba Medical Center · Other Government
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

Our goal is to examine sub lingual versus traditional oral administration of ticagrelor in ACS/non ST-elevation Myocardial Infarction (NSTEMI) patients on platelet reactivity.

Conditions

• Acute Coronary Syndromes
• Non ST Elevation Myocardial Infarction

Interventions

Type	Name	Description
DRUG	Sub Lingual Ticagrelor	180mg sub-lingual ticagrelor

Timeline

• Start date: 2015-07-01
• Primary completion: 2016-03-01
• Completion: 2016-03-01
• First posted: 2015-03-30
• Last updated: 2016-03-22

Locations

1 site across 1 country: Israel